Popular on Rezul
- Atlanta Luxury Real Estate Enters a New Era of Wellness-Focused Living
- Vallejo Home Prices Are Down—"The Price is Right" is Not Just a Game Show
- The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
- Guide Helps Homebuyers and Sellers Understand How Solar Panels Impact RE
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof
- Houston Citywide Office | Market Report Q2 2026
- Crossroads4Hope Announces The Lipschutz Women's Fund
- Ashlar Homes Welcomes Buyers to Fox Hollow, a New Community in Spring Hill, Kansas
- Anamorphic 3D Only Works on Fixed Screens. Loud! OOH Put It on a Moving Ad Van for Flood Re
Similar on Rezul
- Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
- Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
- Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
Rezul News/10740299
FAYETTEVILLE, Ark. - Rezul -- Lineus Medical, a leader in vascular access innovation and maker of SafeBreak® Vascular, the first breakaway device for IV lines, today announced the renewal of its agreement with Vizient, one of the nation's largest group purchasing organization (GPO). The renewed contract delivers more competitive pricing for Vizient members, expanding access to SafeBreak Vascular across health systems nationwide.
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on Rezul News
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on Rezul News
- Facebook Marketplace Is Changing How Some Commercial Real Estate Listings Find Buyers and Tenants
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- Homes For Sale Lake Conroe, TX
- The Alistair Apartments Reaches 95% Occupancy in Downtown Lancaster, PA
- Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
Source: Lineus Medical
0 Comments
Latest on Rezul News
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- ID1Verify Launches Remote Video Service for UK Land Registry Verification
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
- The Resort At The Bridge District Opens In West Sacramento
- BUGS AND BYTES LLC Launches ambasSUBTOr™ —The Platform Closing the Intelligence Gap for In
- Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
- 316 Capital Unveils 18-Home Starkville Development in New Video
- Moore Roofing Company Reveals Common Problems Found During Roof Inspections in 73160
- Slotozilla Reports Strong Growth in Q2 2026
- Midwest Pond Features Schedules Late-Summer Pond Maintenance Across Chicagoland
- Flexible Plan Investments Names Carl Resnick President
- 303 Crown Maids Unveils Dedicated Fort Collins House Cleaning Page for Instant Online Booking
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
- No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
- Cerris Builders completes construction of Imeson Park South Building D
- The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
- Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)


